Navigation Links
Drug dosages often incorrect for obese patients
Date:11/15/2007

PORTLAND, Ore. As if severely overweight people didnt already have enough health concerns, experts are raising another red flag the possibility that some of their prescription medications, especially antibiotics, may not be prescribed at the appropriate dosage and could be ineffective.

Because most adult antibiotics are produced in a one size fits all dosage and some doctors are not attuned to this issue, the societal trend towards severe obesity is resulting in more individuals who get inappropriate drug therapies for infectious disease, a new study in the journal Pharmacotherapy suggests.

The number of individuals with the highest body mass index, very obese people, is up 600 percent between 1986 and 2000, said David Bearden, a clinical associate professor in the College of Pharmacy at Oregon State University.

Very obese individuals in some cases, even those with severe infections, may be getting only half the necessary dose of a prescription drug such as an antibiotic, Bearden said. Thats a problem. It could lead not only to antibiotic failure but also an increase in antibiotic resistance, another serious issue.

The problem is somewhat less of a concern with dosages of medications that patients take for extended periods, such as blood pressure or cholesterol medications, because the results of taking those medications are more routinely monitored and dosages can be increased as necessary. Its a particular concern with antibiotics, Bearden said, because they are often used to treat severe or even life-threatening infections, and bad things can happen quickly if the drug is ineffective.

Drug companies are just now becoming more aware of this issue and beginning to test and recommend dosages more appropriate for adults of varying weights, Bearden said. But with older drugs that are commonly used, there often is very little or no data for adjusting dosages. In actual practice the issue is often ignored outright, or educated guesses are made with whatever data is available.

Without more attention, the issue may only get worse, and its not just a U.S. phenomenon. The World Health Organization estimates that 400 million people were obese in 2005 and that the total will increase to 700 million by 2015. It considers these numbers a global pandemic that is affecting low, middle and high-income nations around the world. Obesity is also considered an independent risk factor for surgical site infections and is associated with higher mortality rates in critically ill patients.

Even if the problem is carefully considered, Bearden said, its not simple.

It would be nice if we could just use a simple multiplier to adjust drug dosages for overweight people, Bearden said. But its not that easy. There are a lot of factors that affect drug distribution in the body, including age, weight, kidney function, other disease problems and the type of antibiotic or other drug.

Adipose tissue, or body fat, affects how the human body interacts with drugs. With some drugs it absorbs large amounts of a prescription medication, but with others, it doesnt. And sometimes there is a very fine line between a drug being effective at one dose, ineffective if the dose is too low, and toxic if its too high. All of these issues affect appropriate dosages, and in many situations, the data needed to evaluate the problem simply doesnt exist.

The issue of adjusted drug dosages has been known and addressed in children for decades, experts say, because of the obvious distinction between a 30-pound toddler and a 120-pound youngster. But with adults, far less attention has been given the problem. The medical and pharmaceutical industries often just assume that everyone weighs about 150-170 pounds.

This is enough of an issue that if I were a very obese person being given an antibiotic, I would discuss it with my doctor, Bearden said. Hopefully the doctor will already have considered it and will be able to address your concerns. If not, then its a conversation you need to have, and more medical specialists, including pharmacists, may need to be consulted.


'/>"/>

Contact: David Bearden
beardend@ohsu.edu
503-494-0116
Oregon State University
Source:Eurekalert

Related biology news :

1. Claims of sex-related differences in genetic association studies often not properly validated
2. Why conservation efforts often fail
3. Studies: Children obese due to a host of unhealthy pressures
4. Abnormal fat metabolism underlies heart problems in diabetic patients
5. A new radiation therapy treatment developed for head and neck cancer patients
6. Device helps patients survive, regain function til transplant
7. Diet support helps chronic kidney patients
8. Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials
9. Doctors learn to control their own brains pain responses to better treat patients
10. Jefferson urologists studying regenerated neo-bladder to help spinal cord injury patients
11. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
(Date:4/19/2016)... UAE, April 20, 2016 The ... as a compact web-based "all-in-one" system solution for all ... fingerprint reader or the door interface with integration authorization ... access control systems. The minimal dimensions of the access ... into the building installations offer considerable freedom of design ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology: